Millennium Management
MAIA icon

Millennium Management’s MAIA Biotechnology MAIA Stock Holding History

Millennium Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,811
Closed -$39K – 6832
2022
Q3 		$39K Buy
+11,811
New +$50K ﹤0.01% 6264

Other funds holding MAIA

LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's MAIA Position: Q4 2022 in Review

Millennium Management sold out of MAIA Biotechnology (MAIA) in Q4 2022, closing a stake of 11,811 shares — an estimated $39K sold.

Millennium Management first reported a position in MAIA in Q3 2022 and held it in 1 quarter. The position peaked at $39K in Q3 2022. 6 funds tracked by Wall St. Rank hold MAIA as of Q4 2022.

  • Millennium Management reported no remaining MAIA Biotechnology position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 11,811 MAIA Biotechnology shares in Q4 2022, an estimated $39K.
  • Millennium Management first reported a position in MAIA Biotechnology in Q3 2022 and held it in 1 quarter.
  • Millennium Management's MAIA Biotechnology position peaked at $39K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.